DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slipped 1.27% to $21.74 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.62% to 19,736.69 and Dow Jones Industrial Average falling 0.54% to 44,401.93.
Catalyst Pharmaceuticals Inc. closed $2.53 below its 52-week high ($24.27), which the company achieved on November 8th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.19% to $149.60, Pfizer Inc. $(PFE)$ rose 1.44% to $26.10, and Abbott Laboratories $(ABT)$ fell 0.61% to $114.90.
Trading volume (584,452) remained 329,736 below its 50-day average volume of 914,188.
Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 09, 2024 17:24 ET (22:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments